SynthesisBMC cancer2019

Impact on prognosis of rebiopsy in advanced non-small cell lung cancer patients after epidermal growth factor receptor-tyrosine kinase inhibitor treatment: a systematic review.

Takuma Imakita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.